Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Christophe Arbet-Engels
Person

Christophe Arbet-Engels

Tracked across 1 events · 6 articles · First seen May 28, 2026 · Last active May 28, 2026

Sentiment
20
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 20
Tech
Altimmune's Pemvidutide Phase 2b Data
Impact: Christophe Arbet-Engels, Chief Medical Officer of Altimmune, expressed confidence in pemvidutide's mechanism and potential based on the positive trial results.
May 28, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Christophe Arbet-Engels live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.